Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors. 2012

Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, People's Republic of China.

Nitroimidazoles and their derivatives have drawn continuing interest over the years because of their varied biological activities, recently found application in drug development for antimicrobial chemotherapeutics and antiangiogenic hypoxic cell radiosensitizers. In order to search for novel antibacterial agents, we designed and synthesized a series of secnidazole analogs based on oxadiazole scaffold (4-21). Among these compounds, 4 and 7-21 were reported for the first time. These compounds were tested for antibacterial activities against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus. This new nitroimidazole derivatives class demonstrated strong antibacterial activities. Escherichia coli β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitory assay and docking simulation indicated that the compounds 2-(2-methoxyphenyl)-5-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-1,3,4-oxadiazole (11) with MIC of 1.56-3.13 μg/mL against the tested bacterial strains and 2-((2-methyl-5-nitro-1H-imidazol-1-yl)methyl)-5-(2-methylbenzyl)-1,3,4-oxadiazole (12) with MIC of 1.56-6.25 μg/mL were most potent inhibitors of Escherichia coli FabH.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000123 Acetyltransferases Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1. Acetyltransferase
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
April 2014, European journal of medicinal chemistry,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
February 2023, Chemistry & biodiversity,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
April 2018, Pest management science,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
April 2013, Chemistry Central journal,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
June 2013, Bioorganic & medicinal chemistry,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
October 2021, Journal of agricultural and food chemistry,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
January 2010, Acta poloniae pharmaceutica,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
August 2021, Pharmaceuticals (Basel, Switzerland),
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
December 2022, Chemical biology & drug design,
Yao Li, and Yin Luo, and Yang Hu, and Di-Di Zhu, and Shuai Zhang, and Zhi-Jun Liu, and Hai-Bin Gong, and Hai-Liang Zhu
August 2021, Archiv der Pharmazie,
Copied contents to your clipboard!